These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26083639)

  • 1. Phenyl Esters Are Potent Inhibitors of Caseinolytic Protease P and Reveal a Stereogenic Switch for Deoligomerization.
    Hackl MW; Lakemeyer M; Dahmen M; Glaser M; Pahl A; Lorenz-Baath K; Menzel T; Sievers S; Böttcher T; Antes I; Waldmann H; Sieber SA
    J Am Chem Soc; 2015 Jul; 137(26):8475-83. PubMed ID: 26083639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure at 1.9A of E. coli ClpP with a peptide covalently bound at the active site.
    Szyk A; Maurizi MR
    J Struct Biol; 2006 Oct; 156(1):165-74. PubMed ID: 16682229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Amino Diphenyl Phosphonates as Novel Inhibitors of Escherichia coli ClpP Protease.
    Moreno-Cinos C; Sassetti E; Salado IG; Witt G; Benramdane S; Reinhardt L; Cruz CD; Joossens J; Van der Veken P; Brötz-Oesterhelt H; Tammela P; Winterhalter M; Gribbon P; Windshügel B; Augustyns K
    J Med Chem; 2019 Jan; 62(2):774-797. PubMed ID: 30571121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ClpP N-terminus coordinates substrate access with protease active site reactivity.
    Jennings LD; Bohon J; Chance MR; Licht S
    Biochemistry; 2008 Oct; 47(42):11031-40. PubMed ID: 18816064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailored Peptide Phenyl Esters Block ClpXP Proteolysis by an Unusual Breakdown into a Heptamer-Hexamer Assembly.
    Lakemeyer M; Bertosin E; Möller F; Balogh D; Strasser R; Dietz H; Sieber SA
    Angew Chem Int Ed Engl; 2019 May; 58(21):7127-7132. PubMed ID: 30829431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barrel-shaped ClpP Proteases Display Attenuated Cleavage Specificities.
    Gersch M; Stahl M; Poreba M; Dahmen M; Dziedzic A; Drag M; Sieber SA
    ACS Chem Biol; 2016 Feb; 11(2):389-99. PubMed ID: 26606371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of Staphylococcus aureus ClpP Bound to the Covalent Active-Site Inhibitor Cystargolide A.
    Illigmann A; Vielberg MT; Lakemeyer M; Wolf F; Dema T; Stange P; Kuttenlochner W; Liebhart E; Kulik A; Staudt ND; Malik I; Grond S; Sieber SA; Kaysser L; Groll M; Brötz-Oesterhelt H
    Angew Chem Int Ed Engl; 2024 Jan; 63(3):e202314028. PubMed ID: 38029352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into structural network responsible for oligomerization and activity of bacterial virulence regulator caseinolytic protease P (ClpP) protein.
    Gersch M; List A; Groll M; Sieber SA
    J Biol Chem; 2012 Mar; 287(12):9484-94. PubMed ID: 22291011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of tailored human caseinolytic protease P inhibitors.
    Gronauer TF; Mandl MM; Lakemeyer M; Hackl MW; Meßner M; Korotkov VS; Pachmayr J; Sieber SA
    Chem Commun (Camb); 2018 Aug; 54(70):9833-9836. PubMed ID: 30109319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structural basis for the activation and peptide recognition of bacterial ClpP.
    Kim DY; Kim KK
    J Mol Biol; 2008 Jun; 379(4):760-71. PubMed ID: 18468623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAA+ chaperones and acyldepsipeptides activate the ClpP protease via conformational control.
    Gersch M; Famulla K; Dahmen M; Göbl C; Malik I; Richter K; Korotkov VS; Sass P; Rübsamen-Schaeff H; Madl T; Brötz-Oesterhelt H; Sieber SA
    Nat Commun; 2015 Feb; 6():6320. PubMed ID: 25695750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible inhibition of the ClpP protease via an N-terminal conformational switch.
    Vahidi S; Ripstein ZA; Bonomi M; Yuwen T; Mabanglo MF; Juravsky JB; Rizzolo K; Velyvis A; Houry WA; Vendruscolo M; Rubinstein JL; Kay LE
    Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6447-E6456. PubMed ID: 29941580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ureadepsipeptides as ClpP Activators.
    Griffith EC; Zhao Y; Singh AP; Conlon BP; Tangallapally R; Shadrick WR; Liu J; Wallace MJ; Yang L; Elmore JM; Li Y; Zheng Z; Miller DJ; Cheramie MN; Lee RB; LaFleur MD; Lewis K; Lee RE
    ACS Infect Dis; 2019 Nov; 5(11):1915-1925. PubMed ID: 31588734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Characterization of Approved Drugs and Drug-Like Compounds as Covalent
    Sassetti E; Durante Cruz C; Tammela P; Winterhalter M; Augustyns K; Gribbon P; Windshügel B
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible Inhibitors Arrest ClpP in a Defined Conformational State that Can Be Revoked by ClpX Association.
    Pahl A; Lakemeyer M; Vielberg MT; Hackl MW; Vomacka J; Korotkov VS; Stein ML; Fetzer C; Lorenz-Baath K; Richter K; Waldmann H; Groll M; Sieber SA
    Angew Chem Int Ed Engl; 2015 Dec; 54(52):15892-6. PubMed ID: 26566002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipridone Anticancer Compounds Ectopically Activate the ClpP Protease and Represent a New Scaffold for Antibiotic Development.
    Jacques S; van der Sloot AM; C Huard C; Coulombe-Huntington J; Tsao S; Tollis S; Bertomeu T; Culp EJ; Pallant D; Cook MA; Bonneil E; Thibault P; Wright GD; Tyers M
    Genetics; 2020 Apr; 214(4):1103-1120. PubMed ID: 32094149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activators of cylindrical proteases as antimicrobials: identification and development of small molecule activators of ClpP protease.
    Leung E; Datti A; Cossette M; Goodreid J; McCaw SE; Mah M; Nakhamchik A; Ogata K; El Bakkouri M; Cheng YQ; Wodak SJ; Eger BT; Pai EF; Liu J; Gray-Owen S; Batey RA; Houry WA
    Chem Biol; 2011 Sep; 18(9):1167-78. PubMed ID: 21944755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-lactones as specific inhibitors of ClpP attenuate the production of extracellular virulence factors of Staphylococcus aureus.
    Böttcher T; Sieber SA
    J Am Chem Soc; 2008 Nov; 130(44):14400-1. PubMed ID: 18847196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular structure of a novel membrane protease specific for a stomatin homolog from the hyperthermophilic archaeon Pyrococcus horikoshii.
    Yokoyama H; Matsui E; Akiba T; Harata K; Matsui I
    J Mol Biol; 2006 May; 358(4):1152-64. PubMed ID: 16574150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Activation of Human Caseinolytic Protease P (ClpP).
    Stahl M; Korotkov VS; Balogh D; Kick LM; Gersch M; Pahl A; Kielkowski P; Richter K; Schneider S; Sieber SA
    Angew Chem Int Ed Engl; 2018 Oct; 57(44):14602-14607. PubMed ID: 30129683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.